Integer (NYSE:ITGR) & Ivanhoe Capital Acquisition (NYSE:IVAN) Critical Contrast

Integer (NYSE:ITGR) and Ivanhoe Capital Acquisition (NYSE:IVAN) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.

Profitability

This table compares Integer and Ivanhoe Capital Acquisition’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Integer 8.73% 8.46% 4.53%
Ivanhoe Capital Acquisition N/A N/A N/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Integer and Ivanhoe Capital Acquisition, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer 0 0 2 0 3.00
Ivanhoe Capital Acquisition 0 1 0 0 2.00

Integer currently has a consensus target price of $106.00, indicating a potential upside of 15.78%. Ivanhoe Capital Acquisition has a consensus target price of $12.00, indicating a potential upside of 20.97%. Given Ivanhoe Capital Acquisition’s higher probable upside, analysts plainly believe Ivanhoe Capital Acquisition is more favorable than Integer.

Institutional & Insider Ownership

98.4% of Integer shares are held by institutional investors. Comparatively, 53.1% of Ivanhoe Capital Acquisition shares are held by institutional investors. 2.1% of Integer shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Integer and Ivanhoe Capital Acquisition’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Integer $1.07 billion 2.81 $77.26 million $2.77 33.05
Ivanhoe Capital Acquisition N/A N/A -$30,000.00 N/A N/A

Integer has higher revenue and earnings than Ivanhoe Capital Acquisition.

Summary

Integer beats Ivanhoe Capital Acquisition on 9 of the 10 factors compared between the two stocks.

About Integer

Integer Holdings Corp. engages in the manufacture and development of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment includes the cardio and vascular, cardiac and neuromodulation, surgical, orthopedics, and portable medical product lines. The Non-Medical segment comprises customized battery power and management systems, charging and docking stations, and power supplies. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.

About Ivanhoe Capital Acquisition

Ivanhoe Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.